iRhythm Technologies Q1 2026 Earnings Preview
Seeking Alpha News (Wed, 29-Apr 5:35 PM ET)
iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference
Globe Newswire (Tue, 28-Apr 4:05 PM ET)
Globe Newswire (Mon, 27-Apr 8:05 AM ET)
iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
Globe Newswire (Thu, 16-Apr 4:05 PM ET)
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
Globe Newswire (Thu, 16-Apr 9:01 AM ET)
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Thu, 9-Apr 6:44 PM ET)
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
PRNewswire (Thu, 9-Apr 9:49 AM ET)
Globe Newswire (Mon, 30-Mar 8:05 AM ET)
iRhythm Holdings Appoints Jason Patten to its Board of Directors
Globe Newswire (Thu, 12-Mar 4:30 PM ET)
iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results
Globe Newswire (Thu, 19-Feb 4:05 PM ET)
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Irhythm Holdings trades on the NASDAQ stock market under the symbol IRTC.
As of April 30, 2026, IRTC stock price climbed to $127.08 with 719,161 million shares trading.
IRTC has a beta of 0.73, meaning it tends to be less sensitive to market movements. IRTC has a correlation of 0.05 to the broad based SPY ETF.
IRTC has a market cap of $4.18 billion. This is considered a Mid Cap stock.
Last quarter Irhythm Holdings reported $209 million in Revenue and $.29 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.25.
In the last 3 years, IRTC traded as high as $212.00 and as low as $55.92.
The top ETF exchange traded funds that IRTC belongs to (by Net Assets): VTI, IWM, VB, VBK, VXF.
IRTC has underperformed the market in the last year with a price return of +19.2% while the SPY ETF gained +31.1%. IRTC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -14.7% and +2.1%, respectively, while the SPY returned +3.9% and +2.8%, respectively.
IRTC support price is $117.09 and resistance is $124.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IRTC shares will trade within this expected range on the day.